PEG Interferon Alpha 2B and Low-Dose Ara-C in Early Chronic Phase CML
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to see if a new interferon which is given only
once a week with ARA-C works as well as standard interferon and low dose ARA-C. The safety of
this treatment will also be studied.